More News
CO-WRITTEN / PARTNER | editor, Hong Kong
view(s)

Gencor's trailblazing pain treatment blends natural and scientific solutions

Backed by rigorous science, Levagen®+ is clinically supported to relieve pains and enhance recovery.

Gyms and fitness centres were hit hard by the pandemic, forcing many people to be immobile or exercise alone at home. However, without regular exercise or the guidance of professionals, individuals are at greater risk of injury. Unfortunately, individuals tend to resort to non-steroidal anti-inflammatory drugs (NSAIDS) when in pain, however this ultimately leads to a multitude of long-term adverse effects. This is where use of safer and natural alternatives will benefit the wider community.

Levagen®+ is Gencor’s branded palmitoylethanolamide (PEA) – a natural pain-reliever and anti-inflammatory compound that is produced in the body in response to pain, inflammation and stress. However, levels of PEA decrease with age and during times of injury, therefore supplementation is needed to restore natural levels in the body.

Although PEA’s wide-ranging benefits are well understood, a major challenge of supplementing with PEA is its inability to be absorbed efficiently in the body. Levagen®+ overcomes this problem by utilising LipiSperse®, a delivery technology developed by Gencor’s sister company Pharmako Biotechnologies Limited in Australia, that allows PEA to be more easily absorbed by the body.

When it comes to science, Levagen®+ is the most clinically-studied PEA in the world. Numerous published studies have proven Levagen®+’s benefits for a wide range of needs, such as improving joint health, boosting sports performance, and even relieving headaches. It is also suitable for various users, including athletes, seniors, office workers, and the like. Six clinical studies are also currently ongoing, demonstrating Gencor’s continuous investment into gold-standard clinical research to support efficacy and safety.

To further support its safety, Levagen®+ is tested by third-party labs for absence of WADA-banned substances. This means that elite athletes can supplement with Levagen®+ to support their sports performance without any concerns of doping. Levagen®+ is produced by Pharmako Biotechnologies Ltd, in cGMP facilities mandated by TGA, ensuring that ingredients are manufactured at the highest quality and validations.

Because of its proven efficacy and safety, Levagen®+ has been chosen by the world’s top athletes and sports associations to enhance recovery and prevent injuries. Healthspan Elite, the U.K.’s top sports nutrition brand, has launched a commercial product containing Levagen+ that athletes and practitioners can now purchase. Gencor has also partnered with Gloucester Rugby – an elite rugby team in the UK who use Levagen®+ as part of their recovery- and injury-based protocols.

Through innovation, healthcare industry players can stand amongst the crowd by manufacturing products with Levagen®+ and targeting consumers in need of solutions to manage pain, support immunity and boost sports performance.

Gencor Pacific offers an extensive list of branded ingredients and standardised single-herb extracts that are clinically shown to support the needs of various demographics. It combines a rich 6000-year history of Ayurvedic wisdom with rigorous science to deliver natural, pure and clinically studied ingredients. Many of its clinical trials are peer-reviewed, double-blind controlled studies with impressive results. It has offices in California, India, and Hong Kong.

For developing a natural ingredient that eases pain and enhances recovery, Gencor was recognised at the 2020 Designed in Hong Kong Awards - Healthcare Product category.

Watch the interview below to know more about their company and their winning product:

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.